ConductScience.org, home

Paper40949487

Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances.

Mei J and 6 others. MedComm (2020), 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances. Papers, record 40949487. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40949487

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances.
PubMed
Journal
MedComm (2020)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.35, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mei JJialun
2Ding PPeng
3Gao CChuan
4Zhou JJian
5Li ZZhiwei
6Zhang CChangqing
7Gao JJunjiehttps://orcid.org/0000-0003-4820-8524

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References186

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131337756Mitochondrially-targeted APOBEC1 is a potent mtDNA mutator affecting mitochondrial function and organismal fitness in Drosophila.Nat Commun2019https://conductscience.org/library/papers/31337756PubMed
227502083A novel mutation m.8561C>G in MT-ATP6/8 causing a mitochondrial syndrome with ataxia, peripheral neuropathy, diabetes mellitus, and hypergonadotropic hypogonadism.J Neurol2016https://conductscience.org/library/papers/27502083PubMed
327626666A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease.Cell Rep2016https://conductscience.org/library/papers/27626666PubMed
419933107Breaking the code of DNA binding specificity of TAL-type III effectors.Science2009https://conductscience.org/library/papers/19933107PubMed
526170609Leber hereditary optic neuropathy: current perspectives.Clin Ophthalmol2015https://conductscience.org/library/papers/26170609PubMed
62102678A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.Nature1990https://conductscience.org/library/papers/2102678PubMed
732202065Mitochondrial DNA in inflammation and immunity.EMBO Rep2020https://conductscience.org/library/papers/32202065PubMed
820007601Heterodimeric DNA methyltransferases as a platform for creating designer zinc finger methyltransferases for targeted DNA methylation in cells.Nucleic Acids Res2010https://conductscience.org/library/papers/20007601PubMed
915806097Highly efficient endogenous human gene correction using designed zinc-finger nucleases.Nature2005https://conductscience.org/library/papers/15806097PubMed
1016298089Designer zinc-finger proteins and their applications.Gene2006https://conductscience.org/library/papers/16298089PubMed
1134050192Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo.Nat Commun2021https://conductscience.org/library/papers/34050192PubMed
1225206509Oxidative stress, mitochondrial damage and neurodegenerative diseases.Neural Regen Res2013https://conductscience.org/library/papers/25206509PubMed
1335102133Human cleaving embryos enable efficient mitochondrial base-editing with DdCBE.Cell Discov2022https://conductscience.org/library/papers/35102133PubMed
1428991104International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy.J Neuroophthalmol2017https://conductscience.org/library/papers/28991104PubMed
1535745859Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective.Pharmaceutics2022https://conductscience.org/library/papers/35745859PubMed
1626735016High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.Nature2016https://conductscience.org/library/papers/26735016PubMed
1732641830A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.Nature2020https://conductscience.org/library/papers/32641830PubMed
1835551512Mitochondrial base editor induces substantial nuclear off-target mutations.Nature2022https://conductscience.org/library/papers/35551512PubMed
1927096365Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.Nature2016https://conductscience.org/library/papers/27096365PubMed
2039248161Mitophagy in acute central nervous system injuries: regulatory mechanisms and therapeutic potentials.Neural Regen Res2025https://conductscience.org/library/papers/39248161PubMed

See all 186 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42958081Recombinant human growth hormone exposure preceding multisystem manifestations in a patient with MT-TL1 m.3243 A > G-related mitochondrial disease: a ten-year case report.BMC Neurol2026https://conductscience.org/library/papers/42958081PubMed
42553297Targeting mitochondria for the treatment of neurodegenerative diseases.Front Neurosci2026https://conductscience.org/library/papers/42553297PubMed
42527628Metabolites with a message: impacts on epigenetics and implications for epimetabopathies.EMBO Rep2026https://conductscience.org/library/papers/42527628PubMed
42324372MTA-NPs induce preferential cytotoxicity, oxidative DNA damage, and mitochondrial apoptosis in human Hep-G2 hepatocellular carcinoma cells.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42324372PubMed
42306084Mitochondrial genome microhomology-mediated editing by donor DNA delivery into mitochondria in human cells.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42306084PubMed
41882155TSPO-PET highlights an atypical mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) phenotype.Neurol Sci2026https://conductscience.org/library/papers/41882155PubMed
41751913Somatic Mutations in Nuclear and Mitochondrial Genes of Mitochondrial Proteins in Primary and Recurrent Glioblastoma.Int J Mol Sci2026https://conductscience.org/library/papers/41751913PubMed
41312018CyDENT: A tale of CRISPR-free strand-specific base editor for nuclear and organellar genomes.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/41312018PubMed
40949487Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances.MedComm (2020)2025https://conductscience.org/library/papers/40949487PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40949487

GET https://conductscience.org/api/papers/v1/40949487/references?page=2